EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

A randomized, double‐blind , dose‐controlled study of the use of dexmedetomidine alone for procedural sedation of children and adolescents undergoing MRI scans

Umar Khan, Gregory B Hammer iD, Cassandra Duncan-Azadi, Yasuyuki Suzuki, Deborah Chiles, Sunring Chime, Phillip Chappell iD

Pediatric Anesthesia · 2024

DOI: 10.1111/pan.14857 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Pediatric Anesthesia, 2024. Verfasst von Umar Khan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Assistant Professor of Anesthesiology and Pain Management, Department of Anesthesiology and Pain Management, Children's Health System Texas,…. Hauptthemen laut MEDLINE: Dexmedetomidine, Propofol. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Pfizer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Dexmedetomidine is a selective α 2 ‐adrenergic agonist originally approved for sedation of adults in the intensive care unit and subsequently approved for procedural sedation in adults undergoing medical procedures. Dexmedetomidine is widely used off‐label for procedural sedation in children.

Aims

To evaluate efficacy and safety of monotherapy dexmedetomidine for magnetic resonance imaging procedural sedation of children ≥1month–

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DexmedetomidinePropofolAdolescentChildHumansAdrenergic alpha-2 Receptor AgonistsProcedural SedationHypnotics and SedativesMagnetic Resonance ImagingInfant, NewbornInfantChild, Preschool

Stichwörter der Autor:innen

dexmedetomidinemagnetic resonance imagingpediatricsprocedural sedation

Substanzen

Adrenergic alpha-2 Receptor AgonistsDexmedetomidineHypnotics and SedativesPropofol

Autor:innen und Institutionen

  • Clinical Assistant Professor of Anesthesiology and Pain Management, Department of Anesthesiology and Pain Management, Children's Health System Texas, Dallas, Texas, USA.
  • Professor, Anesthesiology, Perioperative and Pain Medicine, and Pediatrics, Stanford University, Stanford, California, USA.
  • Department of Anesthesiology, Division of Pediatric Anesthesiology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
  • Department of Critical Care and Anesthesia, National Center for Child Health and Development, Tokyo, Japan.
  • Post Approval Clinical Development, Pfizer, Inc., New York, New York, USA.

ORCID-Profile: Gregory B Hammer, Phillip Chappell

Förderung

  • Pfizer

Zitieren

APA

Khan, U., Hammer, G. B., Duncan-Azadi, C., Suzuki, Y., Chiles, D., Chime, S., & Chappell, P. (2024). A randomized, double‐blind , dose‐controlled study of the use of dexmedetomidine alone for procedural sedation of children and adolescents undergoing MRI scans. Pediatric Anesthesia. https://doi.org/10.1111/pan.14857

Vancouver

Khan U, Hammer GB, Duncan-Azadi C, Suzuki Y, Chiles D, Chime S, et al. A randomized, double‐blind , dose‐controlled study of the use of dexmedetomidine alone for procedural sedation of children and adolescents undergoing MRI scans. Pediatric Anesthesia. 2024. doi:10.1111/pan.14857

BibTeX
@article{Khan2024,
  author = {Khan, Umar and Hammer, Gregory B and Duncan-Azadi, Cassandra and Suzuki, Yasuyuki and Chiles, Deborah and Chime, Sunring and Chappell, Phillip},
  title = {A randomized, double‐blind , dose‐controlled study of the use of dexmedetomidine alone for procedural sedation of children and adolescents undergoing MRI scans},
  journal = {Pediatric Anesthesia},
  year = {2024},
  doi = {10.1111/pan.14857}
}
Kostenlos starten →